$100M sweet spot round size
Most of their 7 investments are in rounds between $80M and $110M
2019
Undisclosed raised $75M on September 30, 2022
Investors: Laurion Capital Management LP, Perceptive Advisors, RA Capital Management, L.P., The Invus Group, Pura Vida Investments and CaaS Capital Management
Ventyx Biosciences raised $177M on September 19, 2022
Investors: Great Point Partners, Walleye Capital, Logos Global Management, LP, Woodline Partners LP, Vivo Capital, Redmile Group, Driehaus Capital Management LLC and CaaS Capital Management
HotSpot Therapeutics, Inc. raised $100M on November 29, 2021
Investors: S.R. One Ltd, Monashee Investment Management LLC, Sofinnova Partners, Revelation Partners, B Capital Group, Atlas Venture, LSP (Life Sciences Partners) and CaaS Capital Management
T-knife Therapeutics raised $110M on August 2, 2021
Investors: Andera Partners, Qatar Investment Authority, Sixty Degree Capital, EQT Life Sciences, Casdin Capital, LLC, Versant Ventures, RA Capital Management, L.P. and CaaS Capital Management
Umoja Biopharma raised $210M on June 15, 2021
Investors: Presight Capital, SVB Securities, SoftBank Investment Advisers, Temasek, RTW Investments, LP and CaaS Capital Management
StrideBio, Inc raised $82M on March 16, 2021
Investors: UCB Ventures, Octagon Capital Advisors, Northpond Ventures, UF Innovate | Ventures, Novo Holdings, Takeda UK Limited, Pontifax Venture Capital, Sarepta Therapeutics and CaaS Capital Management
Cyteir Therapeutics raised $80M on February 11, 2021
Investors: Avidity Partners, Venrock, Osage University Partners (OUP), Novo Holdings, Lightstone Ventures, RA Capital Management, L.P. and CaaS Capital Management